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Protective effect of insulin on ischemic renal injury in diabetes tion of the remaining tubuli, tubulointerstitial fibrosis,
mellitus. pronounced infiltration of inflammatory cells as well as
Background. An exceptional susceptibility to unilateral renal glomerulosclerosis [5]. This is in contrast to non-DM
ischemia/reperfusion (I/R) injury resulting in inflammation, fi-
kidneys where only a transient inflammatory responsebrosis, atrophy of the kidney, and end-stage renal disease
is seen after I/R [6, 7].(ESRD) has been demonstrated in the diabetic rat. The aim
The aim of this study was to examine the effect ofof this study was to examine whether insulin treatment would
reduce I/R injury in diabetic kidneys. insulin on the progressive renal injury that is induced by
Methods. Diabetes mellitus (DM) was induced in male Wistar I/R in DM rats. In order to eliminate not only hyperglyce-
rats by streptozotocin. I/R was achieved by clamping the left mia but also secondary metabolic effects caused by DMrenal artery for 30 minutes. Treatment with long acting insulin
such as formation of glycated proteins, rats were treatedwas started 7 to 14 days before or one day after I/R. Short
with insulin for 7 to 14 days before the ischemic insult.acting insulin was administrated 2 to 6 hours before the injury.
Apoptosis was evaluated six hours after ischemia with the These animals did not receive any insulin after the insult.
TUNEL-method. Four weeks after the clamping inulin clear- We also examined the effect of treatment after the isch-
ance was measured and kidneys were removed for histopatho- emia to investigate the effect of insulin on the progres-
logical evaluation. sion of the injury. When it was evident that insulinResults. In DM animals renal I/R caused massive induction
treatment for an extended period before I/R reducedof apoptosis in the renal medulla after six hours as well as
the injury, we also wanted to determine whether a singleinflammation, fibrosis, renal atrophy and anuria within four
weeks. Treatment with long acting insulin before I/R resulted injection of insulin lowering the blood glucose concentra-
in decreased cell death and an almost complete protection of tion (BGC) just around the time of I/R could prevent
both renal function and histomorphology. Treatment with short the injury.
acting insulin before I/R also decreased the loss of renal func-
Recently, it has been reported that apoptosis in tubulartion. In contrast, insulin treatment after I/R did not protect
cells, especially in the outer medulla, is induced by renalthe kidney from damage.
I/R injury [8, 9]. A correlation between the severity of theConclusions. This study shows that insulin treatment with
a subsequent improved metabolic control before renal I/R pro- injury and the number of apoptotic cells was reported [8].
tected kidneys from ESRD. Insulin-like growth factor 1 (IGF-1), which shares some
structural homologies with insulin, is a known anti-apopto-
tic agent that decreases the injury after renal I/R [9, 10].
Streptozotocin (STZ) diabetic (DM) rats have an in- Insulin by itself has been shown to have anti-apoptotic
creased renal sensitivity to ischemia/reperfusion (I/R) in- effects on epithelial cells from mammary glands [11].
jury [1–4]. Moreover, in DM rats, a comparatively short Since long-acting insulin reduced the damage caused by
ischemia of 30 minutes, which in non-DM rats results in a I/R in DM rats, the question arose as to whether insulin
reversible acute renal failure, causes a progressive injury treatment decreased apoptosis in the kidney during the
with end-stage renal failure within four to eight weeks. acute stage. We therefore compared induction of apopto-
The injury is characterized by tubular atrophy and dila- sis in the kidneys six hours after ischemia in untreated
DM animals, DM animals treated with long-acting insu-
lin for at least a week, and non-DM animals.Key words: diabetes mellitus, ischemia, rat, inflammation, fibrosis, reno-
protection, end-stage renal disease.
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betic by a single injection of STZ. In the first series of of blood samples, and the femoral vein for infusion of
saline (5 mL/kg body weight/h, rats treated with insulinexperiments the rats were subsequently divided into
three groups. One group serving as an untreated control after ischemia and 10 mL/kg body weight/h, rats treated
with insulin before ischemia and untreated rats); thisreceived no insulin treatment. The other two groups
received insulin treatment before or after the ischemic solution also contained 5 mCi/mL 3H-inulin (American
Radiolabeled Chemicals Inc., St. Louis, MO, USA).insult respectively. In a second series of experiments
the animals were divided into two groups of which one After a bolus injection of 1 mL an equilibration period of
45 minutes followed. Urine was then collected separatelyreceived short acting insulin shortly before the ischemic
insult and the other remained untreated. For the entire from each kidney during 30 minutes. In the middle of
this period a reference blood sample was drawn. The 3Hduration of the experiments the animals were kept in
plastic cages and fed standard rat chow (R36; Lactamin activity in plasma and urine was measured by the liquid
scintillation technique.AB, Stockholm, Sweden) and water ad libitum.
Induction of diabetes and measurement of blood Insulin treatment
glucose concentration A long acting insulin, Insulatard MC (Novo, Nordisk
A/S, Bagsvaerd, Denmark), was used. The treatmentThe animals were rendered diabetic by a single in-
jection of STZ (55 mg/kg body weight; Zanosar, Upjohn, started with a dose of 8 U for three days. Thereafter the
dose was adjusted in order to keep the BGC between 5Kalamazoo, MI, USA) into the femoral vein under a
light ether anesthesia or in a tail vein of awake rats. The and 12 mmol/L. If the BGC fell below 5 mmol/L the
dose was decreased by 1 U, and if the BGC rose abovesolution contained 11 mg/mL of STZ in saline with a
sodium citrate buffer, pH 4.0. Prior to the injection the 12 mmol/L the dose was increased by 1 U. This protocol
was followed for treatment with long acting insulin bothrats had been deprived of food overnight but had free
access to water. Food and water consumption, weight before and after ischemia. Treatment before ischemia
started 7 to 14 days before the insult and ended the daygain and the blood glucose levels were recorded to moni-
tor the degree of diabetes. Blood obtained from the tip before renal clamping. Treatment after ischemia started
in the afternoon the day after renal artery clamping.of the tails was analyzed by a modified glucose dehydrog-
enase method (Hemocue, A¨ngelholm, Sweden). The rats In a separate series of experiments short acting insulin
was used. The animals were treated with 10 to 25 unitswere considered diabetic if the blood glucose concen-
tration (BGC) was above 20 mmol/L or if they drank at of Actrapid MC (Novo Nordisk) two to six hours before
renal artery clamping. The efficacy of short acting insulinleast 100 mL/day. At least two weeks elapsed between
the induction of diabetes and the ischemic injury. varied considerably between the animals. Only animals
having a BGC below 10.5 mmol/L prior to anesthesia
Ischemic injury were admitted into the study. Some animals that received
short acting insulin but had a BGC above 10.5 mmol/LThe animals were anesthetized by an intraperitoneal
injection of Eqviticin (a mixture of chloral hydrate 183 after treatment were subsequently included into the
study either as untreated controls or as treated animalsmg/kg body weight, magnesium sulfate 0.09 mg/kg body
weight and thiobarbital sodium 42 mg/kg body weight, with a higher dose of insulin.
Apoteksbolaget, Umea˚, Sweden). During the operation
TUNELthe animals were placed on a servo-controlled heating
pad keeping the body temperature at 37.5C. A left flank The effect of insulin treatment on the development of
apoptosis was evaluated six hours after ischemia/reperfu-incision was made, and the left renal artery was located
and dissected free from its surrounding structures. After sion. The animals were divided into three groups: non-
diabetic, untreated diabetic, and diabetic animals treateda recovery period of 10 minutes, renal ischemia was
produced by clamping the left renal artery for 30 minutes. with long acting insulin for at least one week before I/R
(N  6 in each group). The procedure was otherwiseSubsequently the abdomen was sutured, and the animals
returned to their cages. similar to what is described above. Apoptotic cells were
detected by terminal deoxynucleotidyl transferase (TdT)
Measurement of renal function mediated nick-end-labeling (TUNEL) assay (Roche Di-
agnostics Scandinavia AB, Bromma, Sweden) accordingGlomerular filtration rate was estimated from the clear-
ance of inulin (CIn). The animals were anesthetized by to the recommendations of the manufacturer. Five-micro-
meter thick frozen sections of the kidneys were fixedInactin (Byk Gulden, Konstanz, Germany), put on an
electric heating pad as described above, and tracheosto- in 4% paraformaldehyde in PBS, 20 minutes at room
temperature, and permeabilized by 0.1% Triton X-100mized. Catheters were inserted into both ureters through
a supravesical incision. The right femoral artery was cath- in 0.1% sodium citrate for five minutes on ice. Labeling
mixture (TdT and fluorescein-dUTP, 1:9) was applied,eterized for blood pressure monitoring and withdrawal
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Table 1. Metabolic parameters for rats in experiments with long acting insulin
No treatment Insulin before ischemia Insulin after ischemia
(N  5) (N  6) (N  4)
Food consumption g/day 341 341 383
Water consumption mL/day 16820 15911 16622
Blood glucose before ischemia mmol/L 37.20.7a 2.80.2 34.54.7a
Blood glucose at inulin clearance measurement mmol/L 40.33.9b 36.41.5b 14.25.6
Mean arterial pressure at inulin clearance measurement mm Hg 1066 1224 1246
Body weight four weeks after ischemia g 2235c 24913b 3197
All values are means  SEM. Food and water consumption were recorded before ischemia or insulin treatment.
a P  0.001 vs. insulin before ischemia
b P  0.01 vs. insulin after ischemia
c P  0.001 vs. insulin after ischemia
50 L/section, and the sections were incubated one hour RESULTS
at 37C. Sections were finally rinsed in PBS, mounted Metabolic and physiological parameters for the rats
with Vectashield (Vector Laboratories Inc., Burlingame, in the experiments evaluating long acting insulin are pre-
CA, USA), and analyzed under fluorescence microscope sented in Table 1. Rats treated with insulin before I/R
coupled to an image analysis system Leica Qwin (Leica had lower BGC at the time of ischemia than untreated
Imaging Systems, Cambridge, UK). The apoptotic cells animals and at four weeks post-ischemia the same was true
were defined by intensive green fluorescence of the nu- for rats treated with insulin after ischemia. No difference in
clei, and the number of positive cells was counted at200 mean arterial blood pressure was found at the time when
magnification in five fields, separately in the medulla and the blood sample for inulin measurement was drawn.
the cortex. Results are presented as a number of positive
cells per mm2 in medulla or cortex, respectively. No treatment
In DM rats without insulin treatment the ischemic kid-Histological evaluation
neys were virtually anuric four weeks after the insult
After completion of the functional studies both kid-
whereas the contralateral kidney showed a high urinaryneys were removed and the upper third of each kidney
output and inulin clearance (Fig. 1). This is in accordancewas put into a buffered 4% formalin fixation solution
with our previous findings [5]. The histopathological le-with 1% N-Cetylpyridinium chloride and processed for
sions correlated with renal function (Fig. 2–4). Severehistological examination. The sections were subjected to
lesions were seen in the kidneys with poor function. Theperiodic acid Schiff-staining for detection of basal mem-
dominating features of the lesions were tubular atrophybranes and cell nuclei, and to picro-Sirius staining for
and dilation, infiltration of inflammatory cells and fibro-the investigation of fibrosis. Two investigators indepen-
sis. Papillary necrosis was present in most of the ischemicdently evaluated the histological changes blindly by using
kidneys in the untreated group. The glomeruli were com-coded samples. On the arbitrary scale used, 0 indicated
paratively spared. In rats not receiving insulin treatment,no sign of inflammation, tubular dilation or fibrosis, 1
hypertrophy was seen in the contralateral non-ischemicindicated mild changes, 2 moderate damage, and 3 severe
kidneys. Compared to animals pre-treated with insulinlesions.
the weights of the non-ischemic kidneys were higher in
the untreated group. The weight ratio between ischemicStatistical analyses
and non-ischemic kidneys was also lower in untreatedIn the experiments with long acting insulin, kidneys
rats compared to the animals pre-treated with long actingsubjected to the same treatment (that is, ischemia or no
insulin (Table 2).ischemia) from different groups were compared. Kruskal-
Wallis test was used to compare urinary volume, inulin
Long acting insulin before ischemiaclearance and results from morphological and TUNEL
No difference in urinary production or inulin clearanceevaluations. When significant differences were found
was found between ischemic and non-ischemic kidneysMann-Whitney U-test was used to evaluate differences
in the rats that had been treated with long acting insulinbetween the different groups. Weights, BGC and blood
before the ischemic insult (Fig. 1). There was almost nopressure were compared by a one-way analysis of vari-
evidence of structural renal damage (Figs. 2 and 4), andance (ANOVA) with the Scheffe’s post hoc test. In the
there was no observed decrease in the size of ischemicstudy with short acting insulin, the Student t test was used
instead of ANOVA since only two groups were compared. kidneys four weeks after ischemia.
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Fig. 1. Inulin clearance and urinary flow for each kidney in animals treated with long acting insulin. The different experimental groups are
indicated by the following letters: A, untreated DM animals (N  5); B, animals treated with insulin before I/R (N  6); C, animals treated with
insulin after I/R (N  4). Median values in each group are indicated by horizontal lines. * P  0.05 and ** P  0.01 between groups are indicated
by brackets.
Fig. 2. Semiquantitative morphological evaluation of renal lesions for each kidney in animals treated with long acting insulin. The different
experimental groups are indicated by the following letters: A, untreated DM animals (N  5); B, animals treated with insulin before I/R (N 
6); C, animals treated with insulin after I/R (N  4). Median values in each group are indicated by the horizontal lines. On the arbitrary scale
used: 0  no sign of inflammation, tubular dilation or fibrosis; 1 indicated mild changes; 2  moderate damage; and 3  severe lesions. * P  0.05
and ** P  0.01 between groups as indicated by the brackets.
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Fig. 3. Semiquantitative morphological evaluation of renal lesions for each kidney in the experiments with short-acting insulin showing inflammation,
fibrosis or tubular dilation. The different experimental groups are indicated by the following letters: A, untreated DM animals (N  3); B, animals
treated with insulin before I/R (N  9). The horizontal lines indicate median values in each group. On the arbitrary scale used: 0  no sign of
inflammation, tubular dilation or fibrosis; 1  mild changes; 2  moderate damage; and 3  severe lesions.
Long-acting insulin after ischemia and treated with short acting insulin 229  8 g. Also,
mean arterial pressure values at the time when the bloodTreatment with insulin beginning one day after ische-
sample was drawn for inulin measurement were similar:mia did not produce any improvement of the lesions
untreated 100  4 mm Hg and treated with short acting(Figs. 1, 2, and 4). The same functional pattern was seen
insulin 103  5 mm Hg.in these rats as in the untreated rats: no urine production
in the injured kidney and increased function on the non-
TUNELischemic side. The morphological findings were in accor-
The apoptotic cells were defined by intensive greendance with the functional differences.
fluorescence of the nuclei. Results are presented in Fig-
Short acting insulin before ischemia ure 6. In the untreated diabetic animals high numbers
of positive nuclei could be detected in the tubular cellsTreatment with short acting insulin before renal I/R
of the outer medulla (Fig. 7), whereas only single cellsdecreased the loss of renal function (Fig. 5). However,
were found throughout the cortex. The positive nucleiin the morphological evaluation no improvement could
of the tubular cells were rounded and some of them werebe seen after treatment with short acting insulin (Fig. 3).
clearly reduced in size. Positive nuclei were also foundThe same morphological features were present such as
in the lumen of the tubuli and of the collecting duct.tubular atrophy and dilation, infiltration of inflammatory
These nuclei were irregular in shape and swollen, sug-cells, fibrosis and papillary necrosis. However, there was
gesting that they might belong to necrotic cells that havea difference in the weight of the ischemic kidneys (Ta-
detached from the tubuli. Cells with positive nuclei alsoble 3). The BGC after ischemia was 10.3  0.7 mmol/L
were seen in the interstitium. Significantly less positivefor the animals treated with short acting insulin and
nuclei could be detected in the outer medulla of the41.0  1.1 mmol/L for the untreated rats (P  0.001).
kidneys from the diabetic rats pre-treated with long act-At the time of inulin clearance measurement, BGC was
ing insulin (median 11 nuclei/mm2, 0 to 280 nuclei/mm2)36.6  2.5 mmol/L in the insulin treated and 40.2  3.5
compared to the untreated DM animals (median 332mmol/L in the untreated animals. The body weights were
not different between the groups: untreated 222  7 g nuclei/mm2, 54 to 504 nuclei/mm2; P 0.05). The median
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Fig. 4. Photomicrographs from kidneys four weeks post-ischemia (picro-sirius and PAS staining). The kidneys from the animals that were not
treated with insulin or received long acting insulin after the ischemic insult show severe damage. In the specimens stained with picro-sirius, fibrosis
and tubular dilation can be seen. In the PAS-stained kidneys, inflammation, tubular atrophy and dilation are seen. Kidneys from animals treated
with long acting insulin before ischemia show an almost normal morphology (original magnification 50 for picro-sirius and 200 for PAS).
Table 2. Kidney weights and kidney weight ratios after long-acting insulin treatment
No treatment Insulin before ischemia Insulin after ischemia
(N  5) (N  6) (N  4)
Non-ischemic g 1.740.11 1.220.07a 1.490.08
Ischemic g 0.960.15 1.340.10 1.070.16
Ischemic/non-ischemic weight ratio 0.550.07 1.090.05a,b 0.740.14
All values are means  SEM.
a P  0.01 vs. no treatment
b P  0.05 vs. insulin after ischemia
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Fig. 5. Inulin clearance and urinary flow for
each kidney in the experiments with short act-
ing insulin. The different experimental groups
are indicated by the following letters: A, un-
treated DM animals (N  3); B, animals
treated with insulin before I/R (N  9). Me-
dian values in each group are indicated by
the horizontal lines. * P  0.05 DM between
groups as indicated by brackets.
Fig. 6. Number of TUNEL-positive nuclei per
mm2 in the renal medulla and cortex six hours
after ischemia. Treatment with long acting in-
sulin started at least one week before I/R.
Median values in each group are indicated by
the horizontal lines. N 6 in each group. *P
0.05 between groups as indicated by brackets.
number of nuclei in the medulla in the non-DM group
was 22 nuclei/mm2, 3 to 834 nuclei/mm2. At least four
non-ischemic kidneys were evaluated from each group
and all of them had less than four positive nuclei perTable 3. Kidney weights after short-acting insulin treatment
mm2. In the TUNEL experiments BGC before ischemia
No treatment Insulin before ischemia in non-DM rats was 7.4  0.4 mmol/L, in insulin treated(N3) (N9)
DM rats 2.7  0.2 mmol/L, and in untreated DM rats
Non-ischemic g 1.600.24 1.550.11
45.9  3.0 mmol/L (P  0.001 compared to the non-DMIschemic g 1.090.05 1.640.13a
and insulin treated groups). Body weight at the time ofAll values are means  SEM.
a P  0.05 vs. no treatment clamping was in untreated DM rats 232  9 g. Non-DM
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Fig. 7. Detection of cell death by TUNEL in
the renal medulla six hours after ischemia. (A)
Kidney from an untreated DM animal. A large
number of positive nuclei defined by fluores-
cence are seen in the tubuli and some in the
interstitium of the outer medulla in the kidney
from the untreated DM animal. (B) Kidney
from a DM animal treated with long acting
insulin one week before ischemia. No apo-
ptotic cells are detected in this picture. (Origi-
nal magnification 200).
rats weighed 286  13 g (P  0.01 vs. untreated DM medulla of the untreated DM-rats six hours after I/R
may explain why insulin treatment starting the day afterrats). In the rats treated with long acting insulin the body
the injury fails to decrease the damage. Too many ofweight was 300  7 g (P 0.001 vs. untreated DM rats).
the tubular cells might have already been irreversibly
injured. These data suggest that the conditions before
DISCUSSION and at the time of I/R are crucial for the long-term
We have previously reported that 30 minutes of uni- prognosis, while the conditions afterwards might be less
lateral renal ischemia in DM rats causes a severe pro- important. The observation that apoptosis was mainly
gressive renal injury leading to end-stage renal failure, seen in the renal medulla is consistent with previous
whereas in non-DM rats ischemia of the same duration work [9]. The TUNEL assay is not totally specific for
causes a reversible injury [5]. In the present study, treat- apoptotic cells. Necrotic cells also could be positive using
ment with long acting insulin for at least a week before this method. We saw some positive nuclei with irregular
I/R was a very efficient way to decrease the degree of shapes intraluminally in the tubuli indicating that they
renal injury in DM rats. Treatment with long-acting insu- were necrotic.
lin before the injury also reduced the induction of apo- Insulin per se could have a protective effect against
ptosis in the renal medulla of DM animals after I/R. The renal I/R injury. Voll and Auer stated that insulin de-
second series of experiments showed that short acting creases I/R injury damage independent of the level of
insulin just before the I/R-injury also improved renal glucose in the brain [12]. Insulin has been shown to
function after the injury in DM-rats. Insulin treatment have an anti-apoptotic effect on epithelial cells from the
after I/R did not reduce the degree of injury. This indi- mammary gland [11]. It is speculated that insulin would
cates that the mechanism behind the protective effect of work through the IGF-1 pathway. In high doses insulin
insulin that prevents the progressive renal injury after is able to activate the IGF-1 receptor and exert an anti-
I/R in DM-rats is most efficient before and during the apoptotic effect in vitro; however, the effect is not as
insult. strong as that of IGF-1 [13]. Insulin also can decrease
Our current results show that treatment with long act- the activation of genes that might be harmful in the
ing insulin for a week before I/R reduced the induction setting of I/R in diabetes. For example, mRNA expres-
of apoptosis in the medulla after the injury in DM rats. sion and secretion of angiotensin increased by hypergly-
The number of apoptotic cells has been reported to cor- cemia in cultured immortalized tubular cells is inhibited
relate with the duration of renal ischemia in rats; a longer by insulin despite high glucose concentrations in the cul-
duration of ischemia causes more cells to become apo- ture media [14].
ptotic [8]. Reduction of the extent of apoptosis by anti- The restoration of normoglycemia is another explana-
apoptotic agents, such as insulin-like growth factor-1 tion for the beneficial effects of insulin treatment in the
(IGF-1) and ZVAD-fmk, results in a decreased inflam- present model. Some previous works support the impor-
matory response and improved renal function after I/R tance of BGC in I/R injury. Elevated blood glucose per
[9]. These reports support the hypothesis that apoptosis se has been shown to aggravate the outcome of ischemia
is an important event in the renal response to I/R. Our both in dogs [15] and rats [16]. Dextrose infusion raising
findings of an association between the decreased number the BGC increased serum creatinine up to 30 hours after
of apoptotic cells six hours after ischemia and preserva- I/R combined with uninephrectomy in dogs [16]. Similar
tion of renal function and morphology after four weeks results were obtained in rats where elevated BCG was
in the insulin treated animals are in line with these re- achieved by intraperitoneal glucose injection. In the lat-
ter study the increased sensitivity to I/R during hypergly-ports. The large number of apoptotic cells in the renal
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cemia was associated with renal lactate accumulation. not be achieved with the present insulin treatment. As
found by Daemen and co-workers prevention of apopto-However, in the same study, the insulin treatment that
lowered the lactate levels below that of untreated ani- sis leads to a reduction in the inflammation after I/R [9].
We speculate that in our study, treatment with long-mals did not decrease the sensitivity to I/R-injury in non-
DM rats [15]. Furthermore, in a model of cerebral I/R- acting insulin before I/R, by reducing renal cell death,
could prevent the outburst of inflammatory response.injury, addition of lactate in the fluid surrounding the
brain decreased the damage [17]. Insulin treatment has The findings in this study indicate that once the injury
is established, it is difficult to alter its course.been shown to decrease the degree of cerebral I/R injury
in diabetic rats in a model where it lowered the BGC Early STZ-DM in rats is associated with altered renal
hemodynamics. Glomerular filtration rate and renal[18]. One explanation for the increased renal sensitivity
to I/R injury in STZ-DM could be a higher energy de- plasma flow are increased and these changes can be re-
versed by insulin treatment [25]. It has been suggestedmand due to the increased activity of tubular Na,K-
ATPase [19]. Both the increased activity of Na,K- that the renin-angiotensin system (RAS) is involved in
this process. The effect of DM on RAS has been exten-ATPase and the renal hypertrophy seen in DM could
be reversed by insulin treatment [20]. sively studied. The results have been somewhat conflict-
ing; in most studies the systemic levels of angiotensin IISeveral lines of investigation implicate oxidative stress
as a major factor in renal I/R injury. Induction of anti- and renin were decreased, but some investigators have
found evidence for an intrarenal activation of RAS [26].oxidative enzymes decreases the renal injury after I/R
[21]. Elevation of reactive oxygen species (ROS) in rat RAS could influence the injury not only by its hemo-
dynamic effects but also through the pro-fibrotic actionskidneys subjected to I/R has recently been confirmed,
and treatment with superoxide dismutase decreased apo- via TGF- [27]. The endothelial nitric oxide (NO)-sys-
tem is most likely to be involved in renal I/R injury inptosis in proximal tubular cells in this setting [8]. Hyper-
glycemia also can induce oxidative stress, and for exam- DM. Goor and co-workers found that in DM rats the
plasma and urinary levels of NO metabolites before I/Rple increase lipid peroxidation in cultured tubular cells
[22]. In DM rats treatment with anti-oxidants such as were elevated compared to non-DM animals [1]. How-
ever, after I/R the excretion rate of NO metabolites in-vitamin C and E decreases renal expression of TGF-,
and vitamin C also inhibits renal hypertrophy [23]. The creased in non-DM kidneys and decreased in DM kid-
neys. The authors therefore suggested that a decreasedcombination of an oxidative load from I/R and from
hyperglycemia might raise the oxidative stress further. sensitivity and reduced production of NO could be a
factor in the increased susceptibility to I/R injury in DMThese high levels of ROS may harm the tubular cells and,
for instance, induce apoptosis. The restoration of BGC rats [1]. DM animals have greatly elevated urinary pro-
duction due to osmotic diuresis and one could suspectto normal levels with insulin would then reduce oxidative
stress, and thus, decrease the harm to the kidney. volume depletion as a consequence of this elevation.
However, the DM animals compensate for this by greatlyLike most other chronic renal diseases, diabetic ne-
phropathy is associated with an infiltration of inflamma- increased water consumption, and there is no evidence
for a higher hematocrit in STZ-DM rats compared totory cells. Bohle and co-workers found T-lymphocytes,
fibroblasts, monocytes/macrophages, and a few B-cells non-DM rats [5].
The cytostatic agent STZ is a commonly used drug toin kidneys with diabetic nephropathy [24]. Most studies
of renal I/R injury in non-DM rats describe a transient render experimental animals diabetic. STZ is potentially
nephrotoxic [28–30]. However, studies addressing theinflammation [6, 7]. Combination of I/R with DM re-
sulted in a severe inflammatory response that persisted issue of nephrotoxicity by STZ implicate that in the doses
given to make rats diabetic it does not harm the kidneys.for at least eight weeks [5]. This gave rise to the hypothe-
sis that hyperglycemia in some way sustained the in- STZ is less nephrotoxic than alloxan, which also is used
to make rats diabetic [31, 32]. Insulin treatment reducesflammation once it had started. However, in our study
good glycemic control before and during I/R prevented renal alterations such as tubular vacuolization, mesangial
expansion, glomerular basement membrane thickening,deterioration of renal function despite uncontrolled hy-
perglycemia during the following four weeks. On the and disturbed renal function seen in kidneys of STZ-
DM rats [25, 31, 33, 34]. The present investigation furtherother hand insulin treatment after I/R had no protective
effect on renal function in this study. It was difficult to supports the evidence that renal injury in STZ-DM rats
is due to the effects of the high glucose and that a directachieve a perfect metabolic control with the insulin we
used. In order not to make the animals hypoglycemic, nephrotoxic effect of STZ is unlikely in this model. It
seems evident that a poor metabolic control in combina-elevated blood glucose values immediately before the
next insulin injection had to be allowed. A role of gly- tion with I/R and possibly lack of insulin causes the injury.
In conclusion, insulin treatment for one week beforecemic control in the long-term inflammation and fibrosis
cannot be excluded, since a perfect normoglycemia could renal I/R decreases the structural and functional damage
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